This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Mar 6;90(10):447-448.

doi: 10.1212/WNL.0000000000005073. Epub 2018 Feb 2.

Sifting through a failed Alzheimer trial: What biomarkers tell us about what happened

David S Knopman¹

Affiliations

PMID: 29429973
DOI: 10.1212/WNL.0000000000005073

Editorial

Sifting through a failed Alzheimer trial: What biomarkers tell us about what happened

David S Knopman. Neurology. 2018.

. 2018 Mar 6;90(10):447-448.

doi: 10.1212/WNL.0000000000005073. Epub 2018 Feb 2.

Author

David S Knopman¹

Affiliation

¹ From the Department of Neurology, Mayo Clinic, Rochester, MN. knopman@mayo.edu.

PMID: 29429973
DOI: 10.1212/WNL.0000000000005073

No abstract available

PubMed Disclaimer

Comment on

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab.
Liu E, Wang D, Sperling R, Salloway S, Fox NC, Blennow K, Scheltens P, Schmidt ME, Streffer J, Novak G, Einstein S, Booth K, Ketter N, Brashear HR; ELN115727-301/302 Investigator Group. Liu E, et al. Neurology. 2018 Mar 6;90(10):e877-e886. doi: 10.1212/WNL.0000000000005060. Epub 2018 Feb 2. Neurology. 2018. PMID: 29429971 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information